Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Clinigen Healthcare Limited, Pitcairn House, Crown Square, First Avenue, Burton-on-Trent, Staffordshire, DE14 2WW, United Kingdom
IMMUKIN 2 × 106 IU (0.1 mg) solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. A clear, colourless solution. |
Each vial (0,5 ml) contains 2 × 106 IU (0.1 mg) recombinant human interferon gamma-1b. Interferon gamma-1b is produced in an E. coli expression system.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Interferon gamma-1b |
It is presumed that interferon gamma-1b increases macrophage cytotoxicity by enhancing the respiratory burst via generation of toxic oxygen metabolites capable of mediating the killing of intracellular micro-organisms. |
| List of Excipients |
|---|
|
D-Mannitol |
3 ml glass vials (Type I borosilicate glass) which are stoppered with grey butyl rubber stoppers with aluminium/polypropylene flip-off type caps.
Pack sizes: 1, 3, 5, 6 and 12 vial(s) in one folding box. Not all pack sizes may be marketed.
Clinigen Healthcare Limited, Pitcairn House, Crown Square, First Avenue, Burton-on-Trent, Staffordshire, DE14 2WW, United Kingdom
PL 31644/0004
29/09/2007
| Drug | Countries | |
|---|---|---|
| IMMUKIN | Hong Kong, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
